Abstract
The use of genetically modified organisms for the production of therapeutic products has revolutionized the pharmaceutical industry in the last three decades. Recombinant therapeutic proteins used today are mainly expressed in bacteria, yeasts, mammalian and insect cell cultures, or in transgenic plants and animals. With more than 500 biotechnology products approved or in development globally, the need for efficient means of therapeutic protein production is apparent. In recent years, microalgae have proven to be an ideal candidate for safer, efficient, and economic means of therapeutic production. In this chapter, we discuss the current status and future perspectives of microalgal expression systems for the production of therapeutic proteins.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
